For years the saga of neutral stem transplantation has been one of the most viable options for the eminent researchers in the international spectrum for the effective treatment of the ailing patients and thus to save the ongoing and posterity of the human civilization from the impending danger. In this regard, it has been announced here today at the European Society for Therapeutic Radiology and Oncology Conference in Istanbul about the potential of the neutral stem transplantation towards becoming a ready methodology of treatment in the due course of investigative studies for many conditions while affecting the nervous system at large. According to the discourse, it has come to the knowledge that it also includes along with multiple sclerosis and spinal cord injury.

But to any sensible mind even though they are ignorant of the scientific measures can pose a very question regarding the essence of the neural stem cells! For their knowledge, neural stem cells are primal cells in fetal brain, which are both generally and naturally derived from the other types of neural and glial cells. It is to be stated in this esteem, that there have been ample laboratory experiments from where the initial data are conducted by the steady means of biological models. They in turn have become proficient to demonstrate that multi-potential neural stem cell* transplantation in a noteworthy manner has enhanced radiation induced-spinal cord injury in these animals. There is a strong anticipation among the scientists hope of the vital utilization of this crucial technique for the sake of the prevention or treat radiation myelopathy which in the precise manner means a critical damage to the spinal cord, that are found within the patients in a developing stage after the receiving of the radiotherapy at the treatment of cancer. The modus operandi in this case is of a special matter for the injecting of precursor neural cells into the irradiated area of the spinal cord of the laboratory animals. At the same time as rejecting the graft the immunosuppressive drug or cyclosporin is given to bring to a close the experimental animals.

While speaking to Dr. Mohi Rezvani hailing the Research Institute of the University of Oxford at Churchill Hospital, UK he emphasized on the need of many more similar studies before this course of action can be used for lending a hand to the people affected with demyelinating diseases. In his own words, "These diseases, in which the myelin sheath** of nerves is destroyed, are difficult to treat and pose a real challenge to doctors and scientists.